Molecular Partners (MOLN) said Tuesday it plans to reduce its workforce by up to 24%, or up to 40 positions.
The company said it expects its cash runway to extend into 2028, beyond its previous outlook of 2027, as a result of the job cuts.
Molecular Partners expects the full implementation of the changes to be enacted by the end of this year and the cost reduction to become fully effective in early 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.